How is HGH Fragment 176-191 administered?
This describes how HGH Fragment 176-191 is typically administered in clinical and research references, not a self-administration guide. The usual route is Subcutaneous, on a 1-2x daily, fasted schedule, generally over 8-12 weeks. Specific dosing is individual and beyond general information, and human evidence for HGH Fragment 176-191 is limited.
Administration at a glance (reference data)
- Route: Subcutaneous
- Schedule: 1-2x daily, fasted
- Cycle length: 8-12 weeks
- Half-life: ~30 minutes
References
- The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice — Heffernan M, Summers RJ, Thorburn A, et al., Endocrinology, 2001
- Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone — Ng FM, Sun J, Sharma L, et al., Hormone Research, 2000
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on HGH Fragment 176-191
Full HGH Fragment 176-191 breakdownHGH Fragment 176-191 what it's used forHGH Fragment 176-191 side effectsHGH Fragment 176-191 mistakes to avoidHGH Fragment 176-191 who should avoid itHGH Fragment 176-191 half-lifeHGH Fragment 176-191 how long to workHGH Fragment 176-191 legal statusHGH Fragment 176-191 how it worksaod 9604 vs hgh frag 176 191Ask the AI Coach
Last updated 2026-06-15.